These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 21829175

  • 1. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.
    Bortolanza S, Nonis A, Sanvito F, Maciotta S, Sitia G, Wei J, Torrente Y, Di Serio C, Chamberlain JR, Gabellini D.
    Mol Ther; 2011 Nov; 19(11):2055-64. PubMed ID: 21829175
    [Abstract] [Full Text] [Related]

  • 2. Direct interplay between two candidate genes in FSHD muscular dystrophy.
    Ferri G, Huichalaf CH, Caccia R, Gabellini D.
    Hum Mol Genet; 2015 Mar 01; 24(5):1256-66. PubMed ID: 25326393
    [Abstract] [Full Text] [Related]

  • 3. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.
    Gabellini D, D'Antona G, Moggio M, Prelle A, Zecca C, Adami R, Angeletti B, Ciscato P, Pellegrino MA, Bottinelli R, Green MR, Tupler R.
    Nature; 2006 Feb 23; 439(7079):973-7. PubMed ID: 16341202
    [Abstract] [Full Text] [Related]

  • 4. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
    Feeney SJ, McGrath MJ, Sriratana A, Gehrig SM, Lynch GS, D'Arcy CE, Price JT, McLean CA, Tupler R, Mitchell CA.
    PLoS One; 2015 Feb 23; 10(2):e0117665. PubMed ID: 25695429
    [Abstract] [Full Text] [Related]

  • 5. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B, Ramirez GD, Grasser F, Cheli S, Brunelli S, Mora M, Meneveri R, Marozzi A, Mueller S, Battaglioli E, Ginelli E.
    BMC Biol; 2009 Jul 16; 7():41. PubMed ID: 19607661
    [Abstract] [Full Text] [Related]

  • 6. RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).
    Wallace LM, Garwick-Coppens SE, Tupler R, Harper SQ.
    Mol Ther; 2011 Nov 16; 19(11):2048-54. PubMed ID: 21730972
    [Abstract] [Full Text] [Related]

  • 7. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
    Pistoni M, Shiue L, Cline MS, Bortolanza S, Neguembor MV, Xynos A, Ares M, Gabellini D.
    PLoS Genet; 2013 Nov 16; 9(1):e1003186. PubMed ID: 23300487
    [Abstract] [Full Text] [Related]

  • 8. Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).
    Jones TI, Parilla M, Jones PL.
    PLoS One; 2016 Nov 16; 11(3):e0150938. PubMed ID: 26942723
    [Abstract] [Full Text] [Related]

  • 9. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
    Hanel ML, Sun CY, Jones TI, Long SW, Zanotti S, Milner D, Jones PL.
    Differentiation; 2011 Feb 16; 81(2):107-18. PubMed ID: 20970242
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy.
    Wallace LM, Liu J, Domire JS, Garwick-Coppens SE, Guckes SM, Mendell JR, Flanigan KM, Harper SQ.
    Mol Ther; 2012 Jul 16; 20(7):1417-23. PubMed ID: 22508491
    [Abstract] [Full Text] [Related]

  • 12. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
    D'Antona G, Brocca L, Pansarasa O, Rinaldi C, Tupler R, Bottinelli R.
    J Physiol; 2007 Nov 01; 584(Pt 3):997-1009. PubMed ID: 17855756
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
    Bisset DR, Stepniak-Konieczna EA, Zavaljevski M, Wei J, Carter GT, Weiss MD, Chamberlain JR.
    Hum Mol Genet; 2015 Sep 01; 24(17):4971-83. PubMed ID: 26082468
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G, Yang F, van Overveld PG, Vedanarayanan V, van der Maarel S, Ehrlich M.
    Hum Mol Genet; 2003 Nov 15; 12(22):2909-21. PubMed ID: 14506132
    [Abstract] [Full Text] [Related]

  • 17. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
    Wuebbles RD, Hanel ML, Jones PL.
    Dis Model Mech; 2009 Nov 15; 2(5-6):267-74. PubMed ID: 19383939
    [Abstract] [Full Text] [Related]

  • 18. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
    Richards M, Coppée F, Thomas N, Belayew A, Upadhyaya M.
    Hum Genet; 2012 Mar 15; 131(3):325-40. PubMed ID: 21984394
    [Abstract] [Full Text] [Related]

  • 19. Facioscapulohumeral muscular dystrophy.
    Tawil R.
    Curr Neurol Neurosci Rep; 2004 Jan 15; 4(1):51-4. PubMed ID: 14683629
    [Abstract] [Full Text] [Related]

  • 20. Facioscapulohumeral Muscular Dystrophy.
    DeSimone AM, Pakula A, Lek A, Emerson CP.
    Compr Physiol; 2017 Sep 12; 7(4):1229-1279. PubMed ID: 28915324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.